Health

BioNTech posts $721M loss in 2024 due to low demand for COVID-19 vaccines

BioNTech posts $721M loss in 2024 due to low demand for COVID-19 vaccines

German biotech firm's revenues down 27% compared to 2023, according to company's financial report

Diary.
Current events in Turkiye and the world, leaders’ schedules and international events will be on the Diary page